Clinical Trial Update: NCT Neuro Master Match - N²M² (NOA-20) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for NCT03158389 (N²M² NOA-20) across Phase 1/Phase 2 completed, investigating glioblastoma in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: University Hospital Heidelberg | Conditions: Glioblastoma, Adult | Phase 1, Phase 2 | Status: COMPLETED